Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology

Neutropenia Clinical Trials

A listing of Neutropenia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Florida

Research- Hen/Onc Associates of the Treasure Coast
Port St. Lucie Florida 34952

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda Maryland 20892

Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide

New York

Memorial Sloan-Kettering Cancer Center
New York New York 10065

A Phase 4 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Tennessee

Associates in Oncology & Hematology
Chattanooga Tennessee 37421

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Texas

The University of Texas, Health Science Center at San Antonio
San Antonio Texas 78229

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

China

Cancer Institute and Hospital, CAMS
Beijing
Updated

A clinical research study of pegfilgrastim,30mcg/kg, pegfilgrastim, 60mcg/kg, pegfilgrastim, 100mcg/kg and filgrastim, 5mcg/kg for the treatment of Neutropenia

Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing Beijing 100021

Patients are needed to participate in a clinical research study evaluating Pegfilgrastim for the treatment of Neutropenia

Beijing Cancer Hospital
Beijing 100142

Patients are needed to participate in a clinical research study of rHSA/GCSF to evaluate Underdose (Unintentional), Cancer or Tumor

Cancer Institute and Hospital, CAMS
Beijing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Fuzhou General Hospital of Nanjing Military Command
Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

View More »

Fujian cancer hospital
Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Fujian Medical University Union Hospital
Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

The First Affiliated Hospital of Guangzhou Medical University
Guangzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai Pulmonary Hospital
Shanghai Shanghai 200433

A Phase 3 clinical study for patients with NSCLC, Neutropenia or Febrile Neutropenia

Shanghai Chest Hospital
Shanghai

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai Changzheng Hospital
Shanghai

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Tianjin Medical University Cancer Institute and Hospital
Tianjin Tianjin 300060

Patients are needed to participate in a clinical research study evaluating GW003 for the treatment of Chemotherapy-induced Neutropenia or Metastatic Tumors

Tongji Hospital, Tongji Medical College Huazhou University of Science & Technology
Wuhan

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

The First Affiliated Hospital of Xiamen University
Xiamen

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Zhejiang cancer hospital
Zhejiang

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Czech Republic

Research Site
Chomutov 430 12

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Research Site
Horovice 268 31

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Research Site
Praha 10 100 34

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Nemocnice Znojmo
Znojmo 66902

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

France

Hôpital Européen Georges Pompidou - Service Oncologie Médicale
Paris 75908

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Germany

Teva Investigational Site 32284
Aurich

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Teva Investigational Site 32277
Berlin

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Research Site
Bonn 53111

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

University Hospital Cologne
Cologne NRW 50937

A clinical research study of 3M Tegaderm IV securement dressing for the treatment of Catheter-related Bloodstream Infection

Teva Investigational Site 32269
Dresden

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

View More »

Teva Investigational Site 32276
Frechen

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Universitaetsklinik Hamburg-Eppendorf, Med. Klinik II Onkologie, Haematologie
Hamburg 20246

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

MHH
Hannover

A clinical research study of Eligible patients will be treated with Zarzio for the treatment of Severe Chronic Neutropenia

Teva Investigational Site 32270
Herne

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Teva Investigational Site 32275
Köln

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Teva Investigational Site 32281
Mülheim a. R.

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Teva Investigational Site 32288
Stolberg

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Research Site
Troisdorf 53840

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Italy

Azienda Ospedaliero Universitaria "San Giovanni Battista di Torino"
Torino 10126

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Japan

Nagoya University Graduate School of Medicine
Nagoya 466-8550

A clinical trial seeking patients for a research study for the treatment of Febrile Neutropenia

Korea, Republic of

Busan

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Daegu

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Daejeon

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Goyang

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Hwasun

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

View More »

Seoul

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Suwon

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Poland

Research Site
Bialystok 15-027

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Bydgoszcz

Patients are needed to participate in a clinical research study evaluating Maxy-G34 for the treatment of Chemotherapy-Induced Neutropenia or Breast Cancer

First 1 2 Last